Octave Specialty Group Q1 revenue up 66% to $104 million; loss narrows to $7 million
Octave Specialty Group reported first-quarter 2026 results, with total revenue from continuing operations rising 66% to $104 million, driven by its Insurance Distribution segment and the October 2025 ArmadaCare acquisition. The net loss attributable to shareholders narrowed to $6.9 million, or $0.13 per diluted share, from $46.4 million, or $1.21 per share, a year earlier, though the Specialty P&C Insurance segment posted a loss tied to a litigation settlement.
Key points
- Total revenues from continuing operations were $104 million, up 66% from $63 million; organic revenue growth in Insurance Distribution was 42%.
- Net loss attributable to shareholders was $6.9 million, or $0.13 per diluted share, compared with $46.4 million, or $1.21 per share, in Q1 2025.
- Specialty P&C Insurance segment net loss was $7.7 million, driven primarily by $2.1 million of losses and $5.8 million of LAE from settling a potential litigation matter.
- Adjusted EBITDA to shareholders was $20.1 million, compared with a loss of $1.3 million in Q1 2025; the company will discuss results on a May 7, 2026 call.
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.